719sek
0,0 %
Date:2025-06-04Time:18:00:00Latest report:Q1-2025List:Small CapTicker:IRLAB A
Market Cap:373 msekEnterprise Value:351 msekNet Sales:99,0 msekEarnings:-78,1 msekEmployees:0ISIN:SE0012675361

Ratios

10-year key figure history for IRLAB Therapeutics turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for IRLAB Therapeutics with index and moving average MA50 and MA200.

Stockprice:7,19
MA50:7,17
MA200:11,22
Price/MA200:-35,9 %
RSI (14):52,0
Price/MA50:0,2 %

Description

IRLAB Therapeutics is a Swedish research and pharmaceutical company. The research is based on the company's own research platform and specializes in the treatment of brain diseases, commonly referred to as neurodegenerative diseases. At the present, the company holds drug candidates specializing in, among other things, Parkinson's disease. The head office is located in Gothenburg.

Pharmaceuticals